Comments
Loading...

Allarity Therapeutics

ALLRNASDAQ
Logo brought to you by Benzinga Data
$1.01
-0.03-2.40%
At close: -
$1.02
0.005000.49%
After Hours: 4:46 PM EDT

Allarity Therapeutics (NASDAQ:ALLR) Stock, Analyst Ratings, Price Targets, Forecasts

Allarity Therapeutics Inc has a consensus price target of - based on the ratings of 1 analysts. The high is issued by on . The low is issued by on . The 1 most-recent analyst ratings were released by Ladenburg Thalmann on May 27, 2022, respectively. With an average price target of $8 between Ladenburg Thalmann, there's an implied 684.31% upside for Allarity Therapeutics Inc from these most-recent analyst ratings.

Analyst Ratings for Allarity Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Allarity Therapeutics (ALLR) stock?

A

The latest price target for Allarity Therapeutics (NASDAQ:ALLR) was reported by Ladenburg Thalmann on August 23, 2022. The analyst firm set a price target for $0.00 expecting ALLR to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Allarity Therapeutics (ALLR)?

A

The latest analyst rating for Allarity Therapeutics (NASDAQ:ALLR) was provided by Ladenburg Thalmann, and Allarity Therapeutics downgraded their neutral rating.

Q

When was the last upgrade for Allarity Therapeutics (ALLR)?

A

There is no last upgrade for Allarity Therapeutics

Q

When was the last downgrade for Allarity Therapeutics (ALLR)?

A

The last downgrade for Allarity Therapeutics Inc happened on August 23, 2022 when Ladenburg Thalmann changed their price target from N/A to N/A for Allarity Therapeutics Inc.

Q

When is the next analyst rating going to be posted or updated for Allarity Therapeutics (ALLR)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Allarity Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Allarity Therapeutics was filed on August 23, 2022 so you should expect the next rating to be made available sometime around August 23, 2023.

Q

Is the Analyst Rating Allarity Therapeutics (ALLR) correct?

A

While ratings are subjective and will change, the latest Allarity Therapeutics (ALLR) rating was a downgraded with a price target of $0.00 to $0.00. The current price Allarity Therapeutics (ALLR) is trading at is $1.02, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch